CHF / Cardiac Transplant Consultation Wooster Community Hospital - - PowerPoint PPT Presentation

chf cardiac transplant consultation
SMART_READER_LITE
LIVE PREVIEW

CHF / Cardiac Transplant Consultation Wooster Community Hospital - - PowerPoint PPT Presentation

CHF / Cardiac Transplant Consultation Wooster Community Hospital September, 2008 Echocardiogram: Est. LVEF of 15%; 1 2+ MR OSUMC Ross Heart Hospital October, 2008 CHF / Cardiac Transplant Consultation Recommendations:


slide-1
SLIDE 1

CHF / Cardiac Transplant Consultation

  • Wooster Community Hospital

–September, 2008 –Echocardiogram: Est. LVEF of 15%; 1‐2+ MR

  • OSUMC Ross Heart Hospital

–October, 2008 –CHF / Cardiac Transplant Consultation –Recommendations: medical therapy & device optimization –Follow up: considered not a candidate for cardiac transplant secondary a history of psychosocial issues including suicidal ideations earlier in life and medication non compliance

slide-2
SLIDE 2

CHF / Cardiac Transplant Evaluation Cleveland Clinic Foundation

  • Echocardiogram

– March, 2010 – Technically diminished quality study – Dilated LV – Severe global LV systolic dysfunction: LVEF of 10% – Mild global RV systolic dysfunction – Trivial MR

  • Pharmacologic Stress ECG –

Nuclear Imaging

– March, 2010 – ECG: non diagnostic due to ventricular paced rhythm – Nuclear:

  • Dilated non ischemic cardiomyopathy
  • No evidence of infarction or ischemia
  • Abnormal global left ventricular dysfunction with no localizing wall motion

abnormalities

  • LVEF of 25%
slide-3
SLIDE 3

CHF / Cardiac Transplant Evaluation Cleveland Clinic Foundation

  • Exercise ECG –

Metabolic Test

– May, 2010 – 54% PMHR – SBP decrease of 16 mmHg – Peak MET capacity of 3.2 METS – Discontinued secondary to chest pain – 5 year mortality rate of 10.3% – 5 year US government mortality rate of 1% – Peak VO2: 11.2 mg/kg/min – Ventilatory anaerobic threshold: 8/7 ml/kg/min

slide-4
SLIDE 4

CHF / Cardiac Transplant Evaluation Cleveland Clinic Foundation

  • Right Heart Catheterization

– May, 2010 – RA mean: 6 mmHg – RV: 32/6 mmHg – PA: 32/20 mmHg – PA mean: 24 mmHg – PCWP A wave: 24 mmHg – PCWP V wave: 12 mmHg – PCWP mean: 18 mmHg – Thermo CO: 5.7 l/min – Thermo CI: 2.6 l/min/M^2

slide-5
SLIDE 5

Clinical Course 2010 ‐ 2012

  • Wooster Heart Group

– Out patient follow up visits – Chest pain, dyspnea, fatigue, decreased appetite

  • Wooster Community Hospital

– Recurrent admissions for chests pain and dyspnea

  • Cleveland Clinic Foundation

– Denied cardiac transplant due to mental status issues, medication non compliance, and nicotine use

  • OSUMC Ross Heart Hospital

– Repeat cardiac evaluation and care

slide-6
SLIDE 6

OSUWMC Chest X‐Ray

slide-7
SLIDE 7

OSUWMC Ross Heart Hospital

  • Echocardiogram

– February, 2012 – Severely dilated left ventricle – Severe global LV systolic dysfunction – Estimated LVEF of 15% – Mild LAE – Mild to moderate MR / Mild TR – Estimated RVSP of 35 – 40 mmHg

slide-8
SLIDE 8

OSUWMC Ross Heart Hospital

  • Cardiac Cath

(02/08)

  • Left & Right Heart Cath
  • RA A wave: 24; V wave: 37;

Mean: 21 mmHg

  • RV: 55/21 mmHg
  • PA: 55/33; Mean: 43 mmHg
  • PCWP: A wave: 34; V wave: 35;

Mean: 32 mmHg

  • PA Sat: 54%
  • LV: 88/29 mmHg
  • AO: 88/62; Mean: 72 mmHg
  • Mild non obstructive luminal

irregularities

  • Cardiac Cath

(03/08)

  • Right Heart Cath
  • Dobutamine

2.5 mcg/kg/min

  • RA A wave: 21; V wave: 21;

Mean: 17 mmHg

  • RV: 50/17 mmHg
  • PA: 49/7; Mean: 28 mmHg
  • PCWP: A wave: 30; V wave: 47;

Mean: 32 mmHg

  • PA Sat: 37%
  • Findings c/w: moderate to

severe biventricular failure

slide-9
SLIDE 9

Clinical Course

  • Medical therapy

– ASA, Carvedilol, Furosemide, Warfarin – Home IV Dobutamine infusion

  • Hospice care

– April, 2012 – Palliative care medications – Discontinuation of IV Dobutamine infusion – Deactivation of the ICD

  • Final outcome

– Expired: 7/31/12 of biventricular failure